C07D 261/00
Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
C07D261/00 (Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings) appears on 3,294 US grants and 3,008 published applications in this corpus.
Search patents in C07D- Granted patents
- 3,294
- Published applications
- 3,008
- Assignees
- 1,168
- Inventors
- 8,810
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 26 | 0 |
| 1977 | 45 | 0 |
| 1978 | 43 | 0 |
| 1979 | 28 | 0 |
| 1980 | 47 | 0 |
| 1981 | 48 | 0 |
| 1982 | 23 | 0 |
| 1983 | 31 | 0 |
| 1984 | 25 | 0 |
| 1985 | 35 | 0 |
| 1986 | 24 | 0 |
| 1987 | 29 | 0 |
| 1988 | 19 | 0 |
| 1989 | 31 | 0 |
| 1990 | 45 | 0 |
| 1991 | 47 | 0 |
| 1992 | 23 | 0 |
| 1993 | 57 | 0 |
| 1994 | 46 | 0 |
| 1995 | 45 | 0 |
| 1996 | 94 | 0 |
| 1997 | 74 | 0 |
| 1998 | 61 | 0 |
| 1999 | 81 | 0 |
| 2000 | 66 | 0 |
| 2001 | 81 | 13 |
| 2002 | 71 | 71 |
| 2003 | 75 | 131 |
| 2004 | 67 | 165 |
| 2005 | 64 | 142 |
| 2006 | 76 | 150 |
| 2007 | 89 | 135 |
| 2008 | 71 | 141 |
| 2009 | 77 | 143 |
| 2010 | 116 | 181 |
| 2011 | 104 | 136 |
| 2012 | 120 | 142 |
| 2013 | 130 | 140 |
| 2014 | 132 | 128 |
| 2015 | 114 | 126 |
| 2016 | 94 | 120 |
| 2017 | 130 | 154 |
| 2018 | 115 | 109 |
| 2019 | 90 | 97 |
| 2020 | 79 | 101 |
| 2021 | 66 | 100 |
| 2022 | 67 | 102 |
| 2023 | 55 | 94 |
| 2024 | 41 | 79 |
| 2025 | 46 | 65 |
| 2026 | 31 | 43 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- PAI-1 inhibitors and uses thereof15 Sep 2026US 12,735,402 B2The Cleveland Clinic Foundation
- Low toxicity NMP substitutes and uses thereof25 Aug 2026US 12,715,850 B2Advancion Corporation
- Agrochemical compounds11 Aug 2026US 12,702,134 B2Syngenta Crop Protection AG
- Process for preparing 3-amino-1-butanol and related compounds4 Aug 2026US 12,698,263 B2Advancion Corporation
- Fluorine-containing isoxazolone compound and method for producing the same1 Oct 2026US 2026/0297041 A1Unimatec Co., Ltd.
- Tetraline, phenylcyclobutane and phenylcyclopentane analogs as rxfp1 agonists10 Sep 2026US 2026/0265208 A1Bristol-Myers Squibb Company
- Pai-1 inhibitors and uses thereof20 Aug 2026US 2026/0242355 A1The Cleveland Clinic Foundation
- Process for Preparing Large Size Isoxazoline Particles6 Aug 2026US 2026/0226016 A1Intervet Inc.
- Novel bicyclic-carboxamide compounds useful as pesticides23 Jul 2026US 2026/0206751 A1Syngenta Crop Protection AG
Most cited
By later US patents
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010
- Substituted biphenyl isoxazole sulfonamides222US 5,612,359 ABristol-Myers Squibb Company · 1997
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997
- Glutaramide diuretic agents156US 5,030,654 APfizer Inc. · 1991
- Nitrogen-containing aromatic derivatives135US 7,253,286 B2Eisai Co., Ltd. · 2007